Primary graft dysfunction does not lead to increased cardiac allograft vasculopathy in surviving patients.

[1]  P. Macdonald,et al.  Primary Graft Failure after Heart Transplantation , 2011, Journal of transplantation.

[2]  J. Christie,et al.  Primary graft dysfunction. , 2011, Clinics in chest medicine.

[3]  M. Colvin-adams,et al.  Cardiac allograft vasculopathy: current knowledge and future direction , 2011, Clinical transplantation.

[4]  Paul Aurora,et al.  Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[5]  Seyedhossein Aharinejad,et al.  Donor Serum SMARCAL1 Concentrations Predict Primary Graft Dysfunction in Cardiac Transplantation , 2009, Circulation.

[6]  J. Pilewski,et al.  Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: long-term survival. , 2009, The Annals of thoracic surgery.

[7]  J. Barceló,et al.  RADIAL: a novel primary graft failure risk score in heart transplantation. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[8]  R. Yusen,et al.  Late Primary Graft Dysfunction After Lung Transplantation and Bronchiolitis Obliterans Syndrome , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  A. Bharat,et al.  Immunological link between primary graft dysfunction and chronic lung allograft rejection. , 2008, The Annals of thoracic surgery.

[10]  B. Whitson,et al.  Primary graft dysfunction and long-term pulmonary function after lung transplantation. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  M. Fishbein,et al.  Inflammation/Oxidation in Chronic Rejection: Apolipoprotein A-I Mimetic Peptide Reduces Chronic Rejection of Transplanted Hearts , 2007, Transplantation.

[12]  D. Kaye,et al.  Prolonged cardiac allograft ischemic time – no impact on long‐term survival but at what cost? , 2007, Clinical transplantation.

[13]  S. Visovatti,et al.  Riboflavin-Mediated Reduction of Oxidant Injury, Rejection, and Vasculopathy after Cardiac Allotransplantation , 2007, Transplantation.

[14]  G. Patterson,et al.  Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. , 2007, American journal of respiratory and critical care medicine.

[15]  R. Davis,et al.  Primary graft dysfunction in lung transplantation. , 2006, Seminars in respiratory and critical care medicine.

[16]  M. Kass,et al.  Cardiac allograft vasculopathy: pathology, prevention and treatment , 2006, Current opinion in cardiology.

[17]  N. Banner,et al.  Impaired Left Ventricular Systolic Function Early After Heart Transplantation is Associated with Cardiac Allograft Vasculopathy , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[18]  F. Rosenfeldt,et al.  Early institution of mechanical support improves outcomes in primary cardiac allograft failure. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[19]  P. Tsao,et al.  Prolonged cold ischemia in rat cardiac allografts promotes ischemia-reperfusion injury and the development of graft coronary artery disease in a linear fashion. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  P. Corris,et al.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[21]  Stephen E Kimmel,et al.  The effect of primary graft dysfunction on survival after lung transplantation. , 2005, American journal of respiratory and critical care medicine.

[22]  Ranjit John,et al.  Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list; Implications for donor selection criteria. , 2004, Journal of the American College of Cardiology.

[23]  M. Oz,et al.  Mechanical support for the failing cardiac allograft: a single-center experience. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[24]  G. Haughton.  TRANSPLANTATION ANTIGEN OF MICE: CELLULAR LOCALIZATION OF ANTIGEN DETERMINED BY THE H‐2 LOCUS , 1966, Transplantation.